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INTRODUCTION:  The  presence  of a  mass  in the  epididymis  is not  a common  entity.  The  papillary  cys-
tadenoma  of epididymis  is a benign  tumor  which  may  occur  sporadically  or  as a  characteristic  of  von
Hippel–Lindau  disease.
PRESENTATION OF  CASE:  We  present  a  case  of a 27-year-old  man  with  a  right scrotal  mass  who  was
treated  with  surgical  excision.  Histopathological  examination  revealed  a clear  cell epididymal  papillary
cystadenoma.  A computed  tomography  scan  that  was  performed  later  showed  no  other  abnormality  orpididymis
apillary cystadenoma
on  Hippel–Lindau disease
any  signs  of von  Hippel–Lindau  disease.
DISCUSSION: In this  report,  a case  of  a young  man  suffering  from  this  rare tumor  is  discussed,  focusing
on  the  need  of further  evaluation  in order  to determinate  if  it occurs  as  a feature  of  VHL  disease  or  as  a
sporadic  form.
CONCLUSION:  In unilateral  cases  of papillary  cystadenoma  of  epididymis  such  as  our  patient’s,  literature
advocates  that  no  further  examinations  and  expensive  genetic  testing  is  required.
gical © 2013 Sur
. Introduction
The most common neoplasm of the epididymis is a benign mass
alled “adenomatoid tumor”.1 The papillary cystadenoma (PCE) is
he second most common benign neoplasm2 while leiomyomas3
nd lipomas4 follow in frequency and it may  occur sporadically or as
 characteristic of von Hippel–Lindau disease (VHLD).5 PCE was ﬁrst
escribed in 1956 by Sherrick in a 21-year old patient2; since then,
pproximately 60 reports of such tumors have been published.5
e  discuss a case of a young man  suffering from this rare tumor,
ocusing on the need of further evaluation in order to determinate
f it occurs as a feature of VHL disease or as a sporadic form.
.  Case presentation
A 27-year-old man  presented to our department complaining
f a mild pain in his right scrotum. According to the patient’s his-
ory, a small enlargement of the right epididymal had been noticed months ago. The ﬁrst clinical diagnosis was suggestive of epi-
idymitis so he was treated initially with antibiotics for 3 weeks.
owever, one week after the conclusion of the initial therapy, no
mprovement was mentioned.
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A scrotal ultrasound was performed revealing a well-
circumscribed mass with a complex echo pattern, contiguous to the
head of the right epididymis. Power Doppler indicated increased
tumor vascularity (Fig. 1). Unfortunately, no deﬁnite diagnosis
could be reached through imaging, so diagnostic surgery was
mandatory.
Under general anesthesia, a 3 cm well-circumscribed tumor was
excised along with the right epididymis (Fig. 2). Macroscopically,
the tumor was  hemorrhagic with microcystic consistency and it had
a golden yellow hue (Fig. 3). The patient’s recovery was unevent-
ful. Histopathological examination revealed a clear cell papillary
cystadenoma consisted of clear cells in a papillary–tubular pattern,
mimicking a clear cell renal carcinoma (Fig. 4). The tumor’s mor-
phology, its close relationship with the epidydimis, the presence
of a ﬁbrous capsule and the immunohistochemical results which
were positive for Vimentin, Cytokeratin AE1/AE3, Cytokeratins 7
and 20, while it was negative for CD-10, CEA and p53, determined
the ﬁnal diagnosis.
An  abdominal CT scan was  performed one month after the
surgery and a second one, twelve months later. Neither of them
revealed any abnormality or any signs of VHLD.
3. Discussion
Open access under CC BY-NC-ND license. PCE may  occur as a manifestation of VHLD or sporadically (60%),
mimicking a clear cell renal carcinoma (RCC).5 VHLD is a dominant
autosomal neoplasia syndrome, resulting from a germline mutation
  Y-NC-ND license. 
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Fig. 1. Scrotum ultrasound revealing a tumor with a complex echo pattern.
Fig. 2. Intraoperative ﬁndings revealing the epididymal tumor (marked by red
arrow) contiguous to the right testicle (marked by blue arrow).
i
o
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oFig. 3. Macroscopic appearance of the tumor.n the VHL gene.6 Patients suffering from this syndrome are at risk
f developing various benign and malignant tumors of the central
ervous system, adrenal glands, pancreas, reproductive adnexal
rgans and kidneys. The most common histological type of RCC isFig. 4. Histopathological examination.
the clear cell type and is reported to develop in 24–45% of patients
with VHLD. The mean age of patients with RCC associated with the
VHLD is 37 years, an age at which both RCC and clear cell papillary
cystadenoma are viable considerations in the differential diagnosis
of an epididymal or mesosalpingeal clear cell tumor.
In  the majority of cases, PCE develops within the efferent duc-
tules of the head of the epididymis as a partially or completely cystic
or solid lesion measuring about 1–3 cm in diameter and is usually
asymptomatic.6,7 However, in symptomatic patients the most com-
mon presentation is a painless, slowly growing, scrotal swelling.
In rare occasions, they may  present with pain or tenderness in
the scrotum or are found to have an epididymal nodule during
an examination for infertility. The ages of occurrence are 16–65
with a mean age of 36.8 In females, the counterpart of papillary
cystadenoma of the epididymis is represented by papillary tumors
of the broad ligament and peritoneum most of whom are usually
solid, although they may  have distinct cystic spaces. Distinctive
microscopic features were described by Price.13 Allelic loss of the
VHL gene, located on the short arm of chromosome,13 has been
demonstrated in all benign papillary tumors developing in VHL
patients (papillary cystadenoma of the broad ligament, endometri-
oid cystadenoma of the broad ligament, papillary cystadenomas
of the epididymis, papillary tumor of the retroperitoneum).14 Sev-
eral hypoxia-inducible genes are regulated by protein encoded by
the VHL gene, including platelet-derived growth factor (PDGF),
basic ﬁbroblast growth factor (bFGF), erythropoietin, and vascu-
lar endothelial growth factor (VEGF). VEGF overexpression has
been demonstrated in VHL-associated tumors and may  explain the
cyst formation and vascularized stroma present in these tumors.11
Odrzywolski and Mukhopadhyay analyzed in a review 59 cases of
PCE reported in the literature. They found that bilateral PCE is highly
associated with VHLD. Two  thirds of patients with bilateral tumor
had stigmata or were found to be VHLD positive. On the other hand,
the association of unilateral PCE with VHLD is weaker (20.3%).5
A dilemma arises at this point concerning the patients with uni-
lateral PCE tumors. Should we  investigate the chance they have an
undiscovered VHLD or stop any further examination? Price et al.
studied 8 patients which were followed up for a long period, with
intervals ranging from 18 months to 15 years. Among them no
one developed VHLD.9 Furthermore, unilateral PCE has never been
reported as the initial presentation of VHLD.5 The above data advo-
cate that no further examinations and expensive genetic testing is
required in the treatment of unilateral PCE tumors.
Interestingly, the histological differentiation between PCE and
metastatic renal cell carcinoma in epididymis can be difﬁcult.10
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oth are known to develop in von Hippel–Lindau syndrome; they
oth have similar origin from meso-metanephric tissue and they
re both related to VHL protein function which may  disrupt tumor
uppression through hypoxia-inducible factor (HIF) stimulation of
ngiogenesis.6 This may  be a possible explanation of the high vas-
ularity of the VHLD-associated tumors.11 Lectin histochemistry
tudies are helpful in distinguishing between papillary cystade-
oma and metastatic renal cell carcinoma in epididymis thus a
outine examination of kidneys is not always necessary.12
. Conclusion
The discovery of a benign lesion in epididymis, like a papillary
ystadenoma, although rare, is still possible. It may occur sporadi-
ally or as a manifestation of VHLD; however, in the case of VHDL,
he PCE is usually bilateral. In unilateral cases of PCE such as our
atient’s, literature reviews provide evidence against extensive and
xpensive genetic testing for VHLD.
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